Even after COVID-19 crisis, social isolation continues Even after most coronavirus measures have been discontinued, some people are still living in social isolation to avoid COVID-19 exposure.
Tailor-made information will help immigrants make decisions on taking part in screening programmes Immigrants are relatively less likely to take part in preventive screening programmes, such as cancer screening. This is partly due to the language barrier and a lack of knowledge, according to a doctoral thesis by Nora Hamdiui.
Can healthy gut microbes protect us against antibiotic-resistant bacteria? It is largely assumed within the scientific community that a healthy intestinal microbiome can provide resistance against the settling, growth and multiplication of antibiotic-resistant bacteria.
People who work at night are more likely to get infected with coronavirus People who occasionally or regularly work at night are 37% more likely to test positive for coronavirus than people who only work during the daytime. This is one of the conclusions of a study by the RIVM (Netherlands).
Enthusiasm and challenges when adopting a broad view of health More and more parties in the Netherlands, including healthcare and welfare organisations, local authorities and municipal and communal healthcare services, are using so-called ‘broad health concept’.
Patient in Radboudumc not contaminated with the Ebola virus The patient, who was admitted in the Radboud univerisity medical center over the past few days because of a suspected Ebola infection, was proven not to be infected.
Outbreak of avian influenza A (H5N8) in Dutch poultry In November 2014 avian ‘flu has been detected on poultry farms in the Netherlands.
Promising biobased alternatives to substances of very high concern There are many possible biobased alternatives to substances of very high concern (SVHC). Some are even ready to be deployed right away.
European Antibiotic Awareness Day 2014 Tuesday 18 November is European Antibiotic Awareness Day. On this day, throughout Europe, attention is focused on the responsible use of antibiotics for people and animals.
Partnering as effective strategy to bring new drugs to European market Combining strengths in drug discovery and development by partnering with a medium- or large-sized pharmaceutical company increases the likelihood of success in bringing new products to the market f